![](/img/cover-not-exists.png)
OCEAN: a randomized Phase III study of melphalan flufenamide + dexamethasone to treat relapsed refractory multiple myeloma
Schjesvold, Fredrik, Robak, Pawel, Pour, Ludek, Aschan, Johan, Sonneveld, PieterJournal:
Future Oncology
DOI:
10.2217/fon-2020-0024
Date:
March, 2020
File:
PDF, 1.37 MB
2020